Takeda’s next CEO is a familiar face in Massachusetts biotech scene
When Takeda CEO Christophe Weber retires from the company in June 2026, a familiar face among the Massachusetts biotech scene will take over leading the Japanese pharma giant.
FDA approves painkiller designed to eliminate the risks of addiction associated with opioids
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
The MetroWest Daily News15h
Framingham board approves license for Mexican-Korean restaurant. When it will open
A fast-casual restaurant that serves Korean and Mexican food has received approval to open on Route 9 in Framingham.
The Return of Snake Oil
The Trump administration is poised to supercharge America’s appetite for supplements.
MassDOT launches Narcan pilot program to reduce opioid overdoses
MassDOT has launched a new Naloxone pilot program, starting with two locations in Boston and one in Springfield.
Mass. health experts concerned about future of vaccines, ‘anti-science focus’ after RFK Jr.’s confirmation hearing
Some Massachusetts health experts expressed concerns about Robert F. Kennedy Jr.'s potential appointment following his Senate ...